Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation

Domenica Battaglia, Yu Wen Lin, Claudia Brogna, Antonino Crinò, Valeria Grasso, Alessia F. Mozzi, Lucia Russo, Sabrina Spera, Carlo Colombo, Stefano Ricci, Colin G. Nichols, Eugenio Mercuri, Fabrizio Barbetti

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Gain-of-function mutations of KCNJ11 can cause permanent neonatal diabetes mellitus, but only rarely after 6months of age. Specific uncommon mutations KCNJ11give rise to a syndrome defined as developmental delay, epilepsy, and neonatal diabetes (DEND), or - more frequently - to a milder sub-type lacking epilepsy, denoted as intermediate-DEND (iDEND). Our aim was to consider a possible monogenic etiology in a 12-yr-old boy with early onset diabetes and mild neurological features. We studied a subject diagnosed with diabetes at 21months of age, and negative to type 1 diabetes autoantibodies testing. He had learning difficulties during primary school, and a single episode of seizures at the age of 10 yr. We performed direct DNA sequencing of the KCNJ11 gene with subsequent functional study of mutated channels in COSm6 cells. The patient's clinical response to oral glyburide (Glyb) was assessed. Motor coordination was evaluated before and after 6 and 12months of Glyb therapy. Sequencing of the KCNJ11 gene detected the novel, spontaneous mutation S225T, combined with deletion of amino acids 226-232. In vitro studies revealed that the mutation results in a KATP channel with reduced sensitivity to the inhibitory action of ATP. Glyb improved diabetes control (hemoglobin A1c on insulin: 52mmol/mol/6.9%; on Glyb: 36mmol/mol/5.4%) and also performance on motor coordination tests that were impaired before the switch of therapy. We conclude that KCNJ11/S225T, del226-232 mutation caused a mild iDEND form in our patient. KCNJ11 should be considered as the etiology of diabetes even beyond the neonatal period if present in combination with negative autoantibody testing and even mild neurological symptoms.

Original languageEnglish
Pages (from-to)656-660
Number of pages5
JournalPediatric Diabetes
Volume13
Issue number8
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Glyburide
Homeostasis
Glucose
Mutation
Epilepsy
Autoantibodies
KATP Channels
Type 1 Diabetes Mellitus
DNA Sequence Analysis
Genes
Hemoglobins
Adenosine Triphosphate
Learning
Insulin
Amino Acids
Therapeutics

Keywords

  • Developmental delay
  • Glyburide
  • Infancy onset diabetes
  • KCNJ11
  • Mutation

ASJC Scopus subject areas

  • Internal Medicine
  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism

Cite this

Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation. / Battaglia, Domenica; Lin, Yu Wen; Brogna, Claudia; Crinò, Antonino; Grasso, Valeria; Mozzi, Alessia F.; Russo, Lucia; Spera, Sabrina; Colombo, Carlo; Ricci, Stefano; Nichols, Colin G.; Mercuri, Eugenio; Barbetti, Fabrizio.

In: Pediatric Diabetes, Vol. 13, No. 8, 12.2012, p. 656-660.

Research output: Contribution to journalArticle

Battaglia, D, Lin, YW, Brogna, C, Crinò, A, Grasso, V, Mozzi, AF, Russo, L, Spera, S, Colombo, C, Ricci, S, Nichols, CG, Mercuri, E & Barbetti, F 2012, 'Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation', Pediatric Diabetes, vol. 13, no. 8, pp. 656-660. https://doi.org/10.1111/j.1399-5448.2012.00874.x
Battaglia, Domenica ; Lin, Yu Wen ; Brogna, Claudia ; Crinò, Antonino ; Grasso, Valeria ; Mozzi, Alessia F. ; Russo, Lucia ; Spera, Sabrina ; Colombo, Carlo ; Ricci, Stefano ; Nichols, Colin G. ; Mercuri, Eugenio ; Barbetti, Fabrizio. / Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation. In: Pediatric Diabetes. 2012 ; Vol. 13, No. 8. pp. 656-660.
@article{6a04224f651a40d28eaf867b04fde7bd,
title = "Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation",
abstract = "Gain-of-function mutations of KCNJ11 can cause permanent neonatal diabetes mellitus, but only rarely after 6months of age. Specific uncommon mutations KCNJ11give rise to a syndrome defined as developmental delay, epilepsy, and neonatal diabetes (DEND), or - more frequently - to a milder sub-type lacking epilepsy, denoted as intermediate-DEND (iDEND). Our aim was to consider a possible monogenic etiology in a 12-yr-old boy with early onset diabetes and mild neurological features. We studied a subject diagnosed with diabetes at 21months of age, and negative to type 1 diabetes autoantibodies testing. He had learning difficulties during primary school, and a single episode of seizures at the age of 10 yr. We performed direct DNA sequencing of the KCNJ11 gene with subsequent functional study of mutated channels in COSm6 cells. The patient's clinical response to oral glyburide (Glyb) was assessed. Motor coordination was evaluated before and after 6 and 12months of Glyb therapy. Sequencing of the KCNJ11 gene detected the novel, spontaneous mutation S225T, combined with deletion of amino acids 226-232. In vitro studies revealed that the mutation results in a KATP channel with reduced sensitivity to the inhibitory action of ATP. Glyb improved diabetes control (hemoglobin A1c on insulin: 52mmol/mol/6.9{\%}; on Glyb: 36mmol/mol/5.4{\%}) and also performance on motor coordination tests that were impaired before the switch of therapy. We conclude that KCNJ11/S225T, del226-232 mutation caused a mild iDEND form in our patient. KCNJ11 should be considered as the etiology of diabetes even beyond the neonatal period if present in combination with negative autoantibody testing and even mild neurological symptoms.",
keywords = "Developmental delay, Glyburide, Infancy onset diabetes, KCNJ11, Mutation",
author = "Domenica Battaglia and Lin, {Yu Wen} and Claudia Brogna and Antonino Crin{\`o} and Valeria Grasso and Mozzi, {Alessia F.} and Lucia Russo and Sabrina Spera and Carlo Colombo and Stefano Ricci and Nichols, {Colin G.} and Eugenio Mercuri and Fabrizio Barbetti",
year = "2012",
month = "12",
doi = "10.1111/j.1399-5448.2012.00874.x",
language = "English",
volume = "13",
pages = "656--660",
journal = "Pediatric Diabetes",
issn = "1399-543X",
publisher = "Blackwell Munksgaard",
number = "8",

}

TY - JOUR

T1 - Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation

AU - Battaglia, Domenica

AU - Lin, Yu Wen

AU - Brogna, Claudia

AU - Crinò, Antonino

AU - Grasso, Valeria

AU - Mozzi, Alessia F.

AU - Russo, Lucia

AU - Spera, Sabrina

AU - Colombo, Carlo

AU - Ricci, Stefano

AU - Nichols, Colin G.

AU - Mercuri, Eugenio

AU - Barbetti, Fabrizio

PY - 2012/12

Y1 - 2012/12

N2 - Gain-of-function mutations of KCNJ11 can cause permanent neonatal diabetes mellitus, but only rarely after 6months of age. Specific uncommon mutations KCNJ11give rise to a syndrome defined as developmental delay, epilepsy, and neonatal diabetes (DEND), or - more frequently - to a milder sub-type lacking epilepsy, denoted as intermediate-DEND (iDEND). Our aim was to consider a possible monogenic etiology in a 12-yr-old boy with early onset diabetes and mild neurological features. We studied a subject diagnosed with diabetes at 21months of age, and negative to type 1 diabetes autoantibodies testing. He had learning difficulties during primary school, and a single episode of seizures at the age of 10 yr. We performed direct DNA sequencing of the KCNJ11 gene with subsequent functional study of mutated channels in COSm6 cells. The patient's clinical response to oral glyburide (Glyb) was assessed. Motor coordination was evaluated before and after 6 and 12months of Glyb therapy. Sequencing of the KCNJ11 gene detected the novel, spontaneous mutation S225T, combined with deletion of amino acids 226-232. In vitro studies revealed that the mutation results in a KATP channel with reduced sensitivity to the inhibitory action of ATP. Glyb improved diabetes control (hemoglobin A1c on insulin: 52mmol/mol/6.9%; on Glyb: 36mmol/mol/5.4%) and also performance on motor coordination tests that were impaired before the switch of therapy. We conclude that KCNJ11/S225T, del226-232 mutation caused a mild iDEND form in our patient. KCNJ11 should be considered as the etiology of diabetes even beyond the neonatal period if present in combination with negative autoantibody testing and even mild neurological symptoms.

AB - Gain-of-function mutations of KCNJ11 can cause permanent neonatal diabetes mellitus, but only rarely after 6months of age. Specific uncommon mutations KCNJ11give rise to a syndrome defined as developmental delay, epilepsy, and neonatal diabetes (DEND), or - more frequently - to a milder sub-type lacking epilepsy, denoted as intermediate-DEND (iDEND). Our aim was to consider a possible monogenic etiology in a 12-yr-old boy with early onset diabetes and mild neurological features. We studied a subject diagnosed with diabetes at 21months of age, and negative to type 1 diabetes autoantibodies testing. He had learning difficulties during primary school, and a single episode of seizures at the age of 10 yr. We performed direct DNA sequencing of the KCNJ11 gene with subsequent functional study of mutated channels in COSm6 cells. The patient's clinical response to oral glyburide (Glyb) was assessed. Motor coordination was evaluated before and after 6 and 12months of Glyb therapy. Sequencing of the KCNJ11 gene detected the novel, spontaneous mutation S225T, combined with deletion of amino acids 226-232. In vitro studies revealed that the mutation results in a KATP channel with reduced sensitivity to the inhibitory action of ATP. Glyb improved diabetes control (hemoglobin A1c on insulin: 52mmol/mol/6.9%; on Glyb: 36mmol/mol/5.4%) and also performance on motor coordination tests that were impaired before the switch of therapy. We conclude that KCNJ11/S225T, del226-232 mutation caused a mild iDEND form in our patient. KCNJ11 should be considered as the etiology of diabetes even beyond the neonatal period if present in combination with negative autoantibody testing and even mild neurological symptoms.

KW - Developmental delay

KW - Glyburide

KW - Infancy onset diabetes

KW - KCNJ11

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=84870051901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870051901&partnerID=8YFLogxK

U2 - 10.1111/j.1399-5448.2012.00874.x

DO - 10.1111/j.1399-5448.2012.00874.x

M3 - Article

C2 - 22694282

AN - SCOPUS:84870051901

VL - 13

SP - 656

EP - 660

JO - Pediatric Diabetes

JF - Pediatric Diabetes

SN - 1399-543X

IS - 8

ER -